Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

Author:

Gore Martin,Powles Ray,Lakhani Anil,Milan Sarah,Maitland Jennifer,Goss Glen,Nandi Ann,Perren Timothy,Forgeson Garry,Treleaven Jennifer,Zuiable Ayed,Porta Fulvio

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Reference31 articles.

1. Amadori S, Papa G, Avvisati G, Fenu S, Monarca B, Petti MC, Pulsoni A, Mandelli F (1984) Sequential combination of high dose Ara-C (HIDAC) and asparaginase (ASP) for the treatment of advanced acute leukaemia and lymphoma. Leuk Res 8: 729?734

2. Barnett MJ, Richards MA, Ganesan TS, Waxman JH, Smith BF, Butler MG, Rohatines AZS, Slevin ML, Lister TA (1985) Central nervous system toxicity of high-dose cytosine arabinoside. Semin Oncol 12 (2 Suppl 3): 227?232

3. Bodey GP, Coltman CA, Freireich EJ, Bonnet JD, Gehan EA, Haut AB, Hewlett JS, McCredit KB, Saiki JH, Wilson HE (1974) Chemotherapy of acute leukaemia?comparison of cytarabine alone and in combination with vincristine, prednisolone and cyclophosphamide. Arch Intern Med 133: 260?266

4. Cantin G, Brennan JK (1984) High dose cytosine arabinoside for acute non-lymphocytic leukaemia. Am J Hematol 16: 59?66

5. Capizzi RL, Poole M, Cooper MR, Richards F II, Stuart JJ, Jackson DV Jr, White DR, Spurr CL, Hopkins JO, Muss HB, Rudnick SA, Wells R, Gabriel D, Ross D (1984) Treatment of poor risk acute leukaemia with sequential high dose Ara-C and asparaginase. Blood 63: 694?700

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3